Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drug Discovery: Overview01:26

Drug Discovery: Overview

10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

10.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.0K
Genetic Screens02:46

Genetic Screens

5.6K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.6K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Experiment-guided AlphaFold3 resolves measurement-consistent protein ensembles.

Nature biotechnology·2026
Same author

Shared multicellular injury programs of acute and chronic kidney disease enable mechanistic patient stratification.

medRxiv : the preprint server for health sciences·2026
Same author

Multi-modal tissue-aware graph neural network for <i>in silico</i> genetic discovery.

bioRxiv : the preprint server for biology·2026
Same author

Gene-centered representation of coding and regulatory variation enables outcome prediction.

bioRxiv : the preprint server for biology·2026
Same author

HumanBase: an interactive AI platform for human biology.

Nature methods·2026
Same author

Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer.

Cancer discovery·2025

相关实验视频

Updated: Jan 13, 2026

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

11.8K

一个基于证据的功能基因组学和药物向评估研究助理.

Ksenia Sokolova1,2, Dmitri Kosenkov1,3, Keerthana Nallamotu4,3

  • 1Princeton Precision Health, Princeton University, Princeton, NJ, USA.

bioRxiv : the preprint server for biology
|January 8, 2026
PubMed
概括
此摘要是机器生成的。

阿尔维萨是一名人工智能研究助理,通过在证据和验证索赔中基础答案来增强生物数据分析. 这提高了生物医学研究的准确性和可追溯性.

更多相关视频

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

893
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.2K

相关实验视频

Last Updated: Jan 13, 2026

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

11.8K
Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

893
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.2K

科学领域:

  • 生物医学信息学 生物医学信息学
  • 人工智能在生物学中的应用
  • 计算生物学 计算生物学

背景情况:

  • 生物数据资源正在扩大,但它们的有效使用受到碎片化和对领域专业知识的需求的阻碍.
  • 生物医学当前的大型语言模型往往产生没有支持或不正确的说法,缺乏来源.
  • 从各种生物数据中合成可靠的结论是劳动密集型和具有挑战性的.

研究的目的:

  • 介绍Alvessa,一个基于证据的代理研究助理,旨在提高生物研究中的可验证性.
  • 解决通用语言模型在处理复杂的生物医学数据和确保声明准确性方面的局限性.
  • 支持可复制和可验证的AI辅助生物研究.

主要方法:

  • 阿尔维萨集成了实体识别,预先验证的生物工具和受数据限制的答案生成.
  • 它对检索的记录进行声明级验证,标记未支持的索赔.
  • 对dbQA (LAB-Bench) 和GenomeArena基准进行了评估,涵盖了各种生物学问题.

主要成果:

  • 与生物医学QA任务的通用语言模型相比,Alvessa显著提高了准确性.
  • 它的性能与以编码为中心的代理相提并论,同时确保完全可追溯的输出.
  • 检测伪造的陈述非常依赖于获取的证据,正如对抗性测试所显示的那样.

结论:

  • 阿尔维萨为人工智能辅助的生物研究提供了可验证和准确的方法,克服了现有LLMs的关键局限性.
  • 该系统在药物发现中展示了实际应用,识别了以文献为中心的方法错过的候选目标.
  • 阿尔维萨和GenomeArena被释放,以促进可复制和可靠的AI驱动的科学发现.